When you hear the term "adverse reaction" in the life sciences industry, you're likely to immediately think about pharmaceutical or medical device products. But as a new guidance document from the US ...

DEAR DR. ROACH: You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the risks. I know the risks are based on data. But I wonder how ...

FIRST ON FOX: The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence, that will streamline publicly accessible reporting of negative or unexpected health ...

The US Food and Drug Administration (FDA) announced it is unifying its various adverse reporting systems into a single system called the Adverse Event Monitoring System (AEMS). The agency said the ...

Dear Dr. Roach: You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the risks. I know the risks are based on data. But I wonder how ...